Pretreatment with miR-126-inhibitors bring down the reduction of VEGF and the increase of Ang-1 expression which resulted in by Niaspan in hyperglycemia-induced HREC cells (P < 0.05, Fig. 6B,C). Here, VEGFA is linked to Hyperglycemia.